Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse panbronchiolitis.

Venerino Poletti1, Marco Chilosi, Gianluca Casoni

  • 1Department of Diseases of the Thorax, GB Morgagni Hospital, Forli, Italy. vepolet@tin.it

Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|July 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cluster analysis for clinical, radiological, and histopathological profiling in chronic pulmonary graft-versus-host disease.

European journal of internal medicine·2025
Same author

The pathogenesis of idiopathic pulmonary fibrosis: from "folies à deux" to "Culprit cell Trio".

Pathologica·2025
Same author

Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma.

Journal of clinical medicine·2025
Same author

Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group.

Archives of pathology & laboratory medicine·2024
Same author

COVID-19. Biology, pathophysiology, and immunology: a pathologist view.

Pathologica·2023
Same author

Pulmonary Pathology Society Survey on Practice Approaches in the Histologic Diagnosis of Fibrotic Interstitial Lung Disease: Consensus and Opportunities.

Archives of pathology & laboratory medicine·2023

Diffuse panbronchiolitis (DPB) is a progressive airway disease. Long-term macrolide antibiotic therapy shows significant improvement in prognosis due to anti-inflammatory effects.

Area of Science:

  • Pulmonology
  • Immunology
  • Infectious Disease

Background:

  • Diffuse panbronchiolitis (DPB) is an idiopathic inflammatory airway disease primarily affecting Japan.
  • It is characterized by progressive, suppurative, and obstructive airway disease, potentially leading to bronchiectasis, respiratory failure, and death if untreated.
  • DPB involves inflammation across all layers of the respiratory bronchioles, distributed throughout both lungs.

Purpose of the Study:

  • To describe the key features of Diffuse Panbronchiolitis (DPB).
  • To highlight diagnostic indicators for DPB.
  • To discuss the role of inflammatory mediators and the therapeutic potential of macrolide antibiotics.

Main Methods:

  • Review of clinical, imaging, and histological features of DPB.

Related Experiment Videos

  • Identification of key inflammatory cells (neutrophils, T-lymphocytes) and cytokines (IL-8, macrophage inflammatory protein-1).
  • Analysis of treatment outcomes with long-term macrolide antibiotic therapy.

    • Main Results:

    • Distinctive imaging and histological findings, coexisting sinusitis, and isolation of Haemophilus influenzae and Pseudomonas aeruginosa aid in DPB recognition.
    • Neutrophils, CD8+ T-lymphocytes, IL-8, and macrophage inflammatory protein-1 are implicated in DPB pathogenesis.
    • Long-term macrolide antibiotic therapy demonstrates significant improvement in prognosis.

    Conclusions:

    • Diffuse panbronchiolitis is a distinct clinicopathological entity requiring prompt recognition.
    • Macrolide antibiotics offer a promising therapeutic strategy for DPB, likely through anti-inflammatory and immunomodulatory mechanisms.
    • Further research into DPB pathogenesis and treatment is warranted.